PHARMACOLOGICAL REPORTS, cilt.68, sa.3, ss.543-549, 2016 (SCI-Expanded)
Background: Ehrlich ascites carcinoma is the one of the animal cancer models having high malignancy and rapid growth resistance. Silibin has reported to be an antioxidant in previous studies. We aimed to investigate the effects of silibin on mouse liver with Ehrlich ascites tumor (EAT) cells in different time periods.